Spread of Pseudomonas fluorescens due to contaminated drinking water in a bone marrow transplant unit

Journal of Clinical Microbiology

Volumn 49, Issue 6, 2011, Pages 2093-2096

  Wong, Vanessa ^a   Levi, Katrina ^a   Baddal, Buket ^b   Turton, Jane ^b   Boswell, Tim C ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CETRIMIDE; CIPROFLOXACIN; CLARITHROMYCIN; COLISTIN; COTRIMOXAZOLE; DRINKING WATER; GENTAMICIN; MEROPENEM; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN; VANCOMYCIN;

ADULT; AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BIOLOGICAL MONITORING; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SURVEILLANCE; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; FEBRILE NEUTROPENIA; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; MALE; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR TYPING; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS INFECTION; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; THROAT CULTURE; WATER CONTAMINATION; WATER SUPPLY;

ADULT; BACTERIAL TYPING TECHNIQUES; BACTERIOLOGICAL TECHNIQUES; CARRIER STATE; CLUSTER ANALYSIS; CROSS INFECTION; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; FEVER OF UNKNOWN ORIGIN; GENOTYPE; HOSPITALS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; PHARYNX; PSEUDOMONAS FLUORESCENS; PSEUDOMONAS INFECTIONS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; WATER MICROBIOLOGY; YOUNG ADULT;

PSEUDOMONAS; PSEUDOMONAS FLUORESCENS;

EID: 79957510218     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02559-10     Document Type: Article

References (18)

1. Anaissie, E. J., S. R. Penzak, and M. C. Dignani. 2002. The hospital water supply as a source of nosocomial infections: a plea for action. Arch. Intern. Med. 162:1483-1492.
2. Blondel-Hill, E., D. A. Henry, and D. P. Speert. 2007. Pseudomonas, p. 734-748. In P. R Murray, E. J. Baron, J. H. Jorgensen, M. L. Landry, and M. A. Pfaller (ed.), Manual of clinical microbiology, 9th ed. ASM Press, Washington, DC.
3. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: 20th informational supplement, M100-S20, vol. 30, no. 3. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Eckmanns, T., et al. 2008. An outbreak of hospital-acquired Pseudomonas aeruginosa infection caused by contaminated bottled water in intensive care units. Clin. Microbiol. Infect. 14:454-458.
5. Gershman, M. D., et al. 2008. Multistate outbreak of Pseudomonas fluorescens bloodstream infection after exposure to contaminated heparinized saline flush prepared by a compounding pharmacy. Clin. Infect. Dis. 47:1372-1379.
6. Hall, J., G. Hodgson, and K. G. Kerr. 2004. Provision of safe potable water for immunocompromised patients in hospital. J. Hosp. Infect. 58:155-158.
7. Hsueh, P. R., et al. 1998. Outbreak of Pseudomonas fluorescens bacteremia among oncology patients. J. Clin. Microbiol. 36:2914-2917.
8. Khabbaz, R. F., et al. 1984. Pseudomonas fluorescens bacteremia from blood transfusion. Am. J. Med. 76:62-68.
9. Moody, M. R., V. M. Young, and D. M. Kenton. 1972. In vitro antibiotic susceptibility of pseudomonads other than Pseudomonas aeruginosa recovered from cancer patients. Antimicrob. Agents Chemother. 2:344-349.
10. Namnyak, S., S. Hussain, J. Davalle, K. Roker, and M. Strickland. 1999. Contaminated lithium heparin bottles as a source of pseudobacteraemia due to Pseudomonas fluorescens. J. Hosp. Infect. 41:23-28.
11. Pier, G. B., and R. Ramphal. 2004. Pseudomonas aeruginosa, p. 2587-2615. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Mandell, Douglas, and Bennett's principles and practice of infectious diseases, 6th ed. Churchill Livingstone, New York, NY.
12. Scott, F. W., and T. L. Pitt. 2004. Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J. Med. Microbiol. 53:609-615.
13. Scott, J., et al. 1988. A fatal transfusion reaction associated with blood contaminated with Pseudomonas fluorescens. Vox Sang. 54:201-204.
14. Siebor, E., et al. 2007. Presumed pseudobacteremia outbreak resulting from contamination of proportional disinfectant dispenser. Eur. J. Clin. Microbiol. Infect. Dis. 26:195-198.
15. Taber, T. E., T. F. Hegeman, S. M. York, R. A. Kinney, and D. H. Webb. 1991. Treatment of Pseudomonas infections in peritoneal dialysis patients. Perit. Dial. Int. 11:213-216.
16. Verbist, L. 1993. Epidemiology and sensitivity of 8625 ICU and hematology/oncology bacterial isolates in Europe. International Study Group. Scand. J. Infect. Dis. Suppl. 91:14-24.
17. Vogel, L., G. Jones, S. Triep, A. Koek, and L. Dijkshoorn. 1999. RAPD typing of Klebsiella pneumoniae, Klebsiella oxytoca, Serratia marcescens and Pseudomonas aeruginosa isolates using standardized reagents. Clin. Microbiol. Infect. 5:270-276.
18. Wilkinson, F. H., and K. G. Kerr. 1998. Bottled water as a source of multiresistant Stenotrophomonas and Pseudomonas species for neutropenic patients. Eur. J. Cancer Care (Engl.) 7:12-14.